ConductScience.org, home

Paper29893409

MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.

Zo RB and 1 other. J Cell Physiol, 2018. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B. Papers, record 29893409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29893409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
PubMed
Journal
J Cell Physiol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.05
iCite
Revised in PubMed
2026-01-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zo RBRabah B
2Long ZZiwenhttps://orcid.org/0000-0001-5959-7014

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell ProliferationMajor topic
DNA (Cytosine-5-)-MethyltransferasesMajor topic
Urinary Bladder NeoplasmsMajor topic
Apoptosis
Cell Line, Tumor
Cell Movement
Female
Gene Expression Regulation, Neoplastic
Humans
Male
MicroRNAs
Neoplasm Invasiveness
Signal Transduction
DNA Methyltransferase 3B

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
41595461HNF4α as a Master Regulator of Epigenetic Dynamics in Epithelial Cells.Genes (Basel)2025https://conductscience.org/library/papers/41595461PubMed
41438999The Role of DNA Methyltransferases in Urinary System Diseases.Cancer Innov2025https://conductscience.org/library/papers/41438999PubMed
41167712miR-124 Targets EGFR and Attenuates Growth and Invasion in Bladder Cancer Cells.In Vivo2025https://conductscience.org/library/papers/41167712PubMed
40088364MicroRNA-124a/Sirtuin 1 pathway inhibits autophagy to promote hepatocyte apoptosis in acute-on-chronic liver failure.Mol Biol Rep2025https://conductscience.org/library/papers/40088364PubMed
39981244Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.Front Immunol2025https://conductscience.org/library/papers/39981244PubMed
39934532miR-124-3p inhibits CRC proliferation, migration, and invasion by targeting ITGB1.Discov Oncol2025https://conductscience.org/library/papers/39934532PubMed
39460871MiR-124-3p inhibits cell stemness in glioblastoma via targeting EPHA2 through ALKBH5-mediated m6A modification.Hum Cell2024https://conductscience.org/library/papers/39460871PubMed
38197221Discovery of novel microRNA mimic repressors of ribosome biogenesis.Nucleic Acids Res2024https://conductscience.org/library/papers/38197221PubMed
38038165Function of microRNA‑124 in the pathogenesis of cancer (Review).Int J Oncol2024https://conductscience.org/library/papers/38038165PubMed
37902910The relationship between DNA methyltransferase 3B (DNMT3B) and miR 124-3pa expressions in bladder cancer tissues.Mol Biol Rep2023https://conductscience.org/library/papers/37902910PubMed
37705098Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.J Transl Med2023https://conductscience.org/library/papers/37705098PubMed
36915057PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression.BMC Womens Health2023https://conductscience.org/library/papers/36915057PubMed
36600320MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling.Biomark Res2023https://conductscience.org/library/papers/36600320PubMed
35958461A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.Am J Transl Res2022https://conductscience.org/library/papers/35958461PubMed
35403137Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.Cancer Diagn Progn2021https://conductscience.org/library/papers/35403137PubMed
35212603The novel circular RNA HIPK3 accelerates the proliferation and invasion of hepatocellular carcinoma cells by sponging the micro RNA-124 or micro RNA-506/pyruvate dehydrogenase kinase 2 axis.Bioengineered2022https://conductscience.org/library/papers/35212603PubMed
35127724Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment.Front Cell Dev Biol2021https://conductscience.org/library/papers/35127724PubMed
35028929Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.Clin Transl Oncol2022https://conductscience.org/library/papers/35028929PubMed
34432285MicroRNAs and Heat Shock Proteins in Breast Cancer Biology.Methods Mol Biol2022https://conductscience.org/library/papers/34432285PubMed
34373692Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1.J Oncol2021https://conductscience.org/library/papers/34373692PubMed

See all 35 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNMT3B1789PubTator's text mininghttps://conductscience.org/library/genes/1789NCBI Gene
MIR124-3406909PubTator's text mininghttps://conductscience.org/library/genes/406909NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29893409

GET https://conductscience.org/api/papers/v1/29893409/cited_by?page=2